SUDEEPPHRM

- The Board recommended a final dividend of ₹1.50/- per equity share for FY 2025-26. - The Record Date for determining entitlement to this dividend is July 23, 2026. - The dividend is subject to approval at the AGM on August 4, 2026.

- The 37th Annual General Meeting (AGM) of Sudeep Pharma Limited is scheduled for Tuesday, 4th August 2026 at 11:00 a.m. (IST) via Video Conferencing/OAVM. - The company has provided web-links to access the Integrated Annual Report for FY 2025-26 and the AGM Notice. - The Record Date for Final Dividend is Thursday, 23rd July 2026, and the Dividend Payment Date is Friday, 7th August 2026. - Remote e-voting will be available from Saturday, 1st August 2026 (09:00 A.M.) to Monday, 3rd August 2026 (05:00 P.M.).

- Notice for 37th Annual General Meeting (AGM) to be held on Tuesday, 4th August 2026, at 11:00 A.M. via Video Conferencing. - Key agenda items include adoption of FY2025-26 financial statements and declaration of a dividend of ₹1.50 per equity share. - Re-appointment of Mr Ajay Shrirang Kandelkar as Whole Time Director with revised remuneration of ₹1,14,97,600 p.a. - Ratification of 'Sudeep Pharma Employee Stock Option Scheme 2025' for company and subsidiary employees.

- Sudeep Pharma Limited's Board appointed Mr. Milin Mehta (DIN: 01297508) as an Additional Director (Non-Executive Non-Independent Director) effective June 26, 2026. - Mr. Mehta is a Chartered Accountant, Law Graduate, and Managing Partner at KC Mehta & Co LLP.

- The Board of Directors of Sudeep Pharma Limited, in its meeting held on June 26, 2026, approved the appointment of Mr. Milin Mehta (DIN: 01297508) as an Additional Non-Executive Non-Independent Director, effective June 26, 2026.

- Sudeep Pharma Limited announced the closure of the trading window for designated persons. - The window will be closed from July 1, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter ending June 30, 2026. - This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations.